Skip to content
PubMed This is a summary of 52 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 52 referenced papers

Top Authors

Ibrahim El‐Battrawy
St. Josef-Hospital
İbrahim Akın
Heidelberg University
Xiaobo Zhou
Heidelberg University
Siegfried Lang
Heidelberg University
Christian Wolpert
Klinikum Ludwigsburg
Rainer Schimpf
Heidelberg University
Henggui Zhang
University of Manchester
Martin Borggrefe
Heidelberg University
Volker Liebe
Heidelberg University
Johanna Besler
Heidelberg University

Top Institutions

Ranked by publications Top 10 institutions
02

Klinikum Ludwigsburg

Ludwigsburg, Germany

7 papers
03

St. Josef-Hospital

Bochum, Germany

15 papers
05

University of Manchester

Manchester, United Kingdom

16 papers

References

References (52)
  1. 1

    Usefulness of exercise test in the diagnosis of short QT syndrome.

    Giustetto C, Scrocco C, Schimpf R, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015; (17(4)):628-34 doi:10.1093/europace/euu351.

    PMID: 25833882
  2. 2

    Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization.

    Cordeiro JM, Zeina T, Goodrow R, et al.

    Journal of molecular and cellular cardiology 2015; (84()):52-60.

    PMID: 25889894
  3. 3

    Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.

    Harrell DT, Ashihara T, Ishikawa T, et al.

    International journal of cardiology 2015; (190()):393-402.

    PMID: 25974115
  4. 4

    Characterization of a Chinese KCNQ1 mutation (R259H) that shortens repolarization and causes short QT syndrome 2.

    Wu ZJ, Huang Y, Fu YC, et al.

    Journal of geriatric cardiology : JGC 2015; (12(4)):394-401 doi:10.11909/j.issn.1671-5411.2015.04.002.

    PMID: 26346102
  5. 5

    Optimal QT interval correction formula in sinus tachycardia for identifying cardiovascular and mortality risk: Findings from the Penn Atrial Fibrillation Free study.

    Patel PJ, Borovskiy Y, Killian A, et al.

    Heart rhythm 2016; (13(2)):527-35.

    PMID: 26552754
  6. 6

    Use of a subcutaneous ICD in a patient with short QT syndrome.

    Mondoly P, Cardin C, Rollin A, et al.

    Clinical case reports 2016; (4(1)):35-8 doi:10.1002/ccr3.432.

    PMID: 26783432
  7. 7

    Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.

    Whittaker DG, Ni H, El Harchi A, et al.

    PLoS computational biology 2017; (13(6)):e1005593 doi:10.1371/journal.pcbi.1005593.

    PMID: 28609477
  8. 8

    In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.

    Luo C, Wang K, Zhang H

    PloS one 2017; (12(6)):e0179515 doi:10.1371/journal.pone.0179515.

    PMID: 28632743
  9. 9

    Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.

    Providência R, Karim N, Srinivasan N, et al.

    Heart (British Cardiac Society) 2018; (104(6)):502-508 doi:10.1136/heartjnl-2017-311673.

    PMID: 28954836
  10. 10

    Multiple clinical profiles of families with the short QT syndrome.

    Akdis D, Saguner AM, Medeiros-Domingo A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(FI1)):f113-f121 doi:10.1093/europace/eux186.

    PMID: 29016797
  11. 11

    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.

    Mazzanti A, Maragna R, Vacanti G, et al.

    Journal of the American College of Cardiology 2017; (70(24)):3010-3015 doi:10.1016/j.jacc.2017.10.025.

    PMID: 29241489
  12. 12

    Modelling the effects of chloroquine on KCNJ2-linked short QT syndrome.

    Luo C, Wang K, Zhang H

    Oncotarget 2017; (8(63)):106511-106526 doi:10.18632/oncotarget.22490.

    PMID: 29290967
  13. 13

    Diagnosis and management of short QT syndrome.

    Bjerregaard P

    Heart rhythm 2018; (15(8)):1261-1267 doi:10.1016/j.hrthm.2018.02.034.

    PMID: 29501667
  14. 14

    Tentative Screening Criteria for Short QT Interval in Children and Adolescents.

    Hazeki D, Ninomiya Y, Ueno K, Yoshinaga M

    Circulation journal : official journal of the Japanese Circulation Society 2018; (82(10)):2627-2633 doi:10.1253/circj.CJ-18-0213.

    PMID: 30047504
  15. 15

    Recent Advances in Short QT Syndrome.

    Campuzano O, Sarquella-Brugada G, Cesar S, et al.

    Frontiers in cardiovascular medicine 2018; (5()):149 doi:10.3389/fcvm.2018.00149.

    PMID: 30420954
  16. 16

    Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.

    Odening KE, Bodi I, Franke G, et al.

    European heart journal 2019; (40(10)):842-853 doi:10.1093/eurheartj/ehy761.

    PMID: 30496390
  17. 17

    Implantable cardioverter defibrillator replacement guided by T wave safety margin in a short QT syndrome patient.

    Shen Y, Pan W, Jiang C, et al.

    Pacing and clinical electrophysiology : PACE 2019; (42(5)):557-559 doi:10.1111/pace.13580.

    PMID: 30548872
  18. 18

    Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome.

    El-Battrawy I, Besler J, Liebe V, et al.

    Journal of the American Heart Association 2018; (7(23)):e010073 doi:10.1161/JAHA.118.010073.

    PMID: 30571592
  19. 19

    Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome.

    El-Battrawy I, Besler J, Ansari U, et al.

    Clinical research in cardiology : official journal of the German Cardiac Society 2019; (108(10)):1140-1146 doi:10.1007/s00392-019-01449-3.

    PMID: 30879093
  20. 20

    Acquired short QT syndrome in a cancer patient treated with Toad.

    Huang Y, Xu Y, Barajas-Martinez H, Hu D

    Pacing and clinical electrophysiology : PACE 2019; (42(9)):1273-1275 doi:10.1111/pace.13708.

    PMID: 31037741
  21. 21

    Short QT Syndrome: A Comprehensive Genetic Interpretation and Clinical Translation of Rare Variants.

    Campuzano O, Fernandez-Falgueras A, Lemus X, et al.

    Journal of clinical medicine 2019; (8(7)) doi:10.3390/jcm8071035.

    PMID: 31315195
  22. 22

    Molecular Insights into the Short QT Syndrome.

    Perike S, McCAULEY MD

    The Journal of innovations in cardiac rhythm management 2018; (2018()):3065-3070 doi:10.19102/icrm.2018.090302.

    PMID: 31355049
  23. 23

    Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome.

    El-Battrawy I, Besler J, Li X, et al.

    Frontiers in pharmacology 2019; (10()):771 doi:10.3389/fphar.2019.00771.

    PMID: 31427960
  24. 24

    Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis.

    Raschwitz LS, El-Battrawy I, Schlentrich K, et al.

    Frontiers in genetics 2019; (10()):1312 doi:10.3389/fgene.2019.01312.

    PMID: 32010184
  25. 25

    Computational Study to Identify the Effects of the KCNJ2 E299V Mutation in Cardiac Pumping Capacity.

    Jeong DU, Lee J, Lim KM

    Computational and mathematical methods in medicine 2020; (2020()):7194275 doi:10.1155/2020/7194275.

    PMID: 32328155
  26. 26

    Management of ventricular electrical storm: a contemporary appraisal.

    Kowlgi GN, Cha YM

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(12)):1768-1780 doi:10.1093/europace/euaa232.

    PMID: 32984880
  27. 27

    Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.

    Lan H, Xu Q, El-Battrawy I, et al.

    Frontiers in pharmacology 2020; (11()):554422 doi:10.3389/fphar.2020.554422.

    PMID: 33154722
  28. 28

    Long-term prognosis of short QT interval in Korean patients: a multicenter retrospective cohort study.

    Kim DY, Uhm JS, Kim M, et al.

    BMC cardiovascular disorders 2021; (21(1)):17 doi:10.1186/s12872-020-01824-3.

    PMID: 33407155
  29. 29

    Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.

    Walsh R, Adler A, Amin AS, et al.

    European heart journal 2022; (43(15)):1500-1510 doi:10.1093/eurheartj/ehab687.

    PMID: 34557911
  30. 30

    Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes into clinical care.

    Sandhu U, Kovacs AH, Nazer B

    Heart rhythm O2 2021; (2(6Part B)):832-839 doi:10.1016/j.hroo.2021.09.011.

    PMID: 34988534
  31. 31

    Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.

    Du C, Rasmusson RL, Bett GC, et al.

    Frontiers in pharmacology 2021; (12()):794620 doi:10.3389/fphar.2021.794620.

    PMID: 35115940
  32. 32

    Inwardly Rectifying Potassium Channel Kir2.1 and its "Kir-ious" Regulation by Protein Trafficking and Roles in Development and Disease.

    Hager NA, McAtee CK, Lesko MA, O'Donnell AF

    Frontiers in cell and developmental biology 2021; (9()):796136 doi:10.3389/fcell.2021.796136.

    PMID: 35223865
  33. 33

    Variable Clinical Appearance of the Kir2.1 Rare Variants in Russian Patients with Long QT Syndrome.

    Zaklyazminskaya E, Polyak M, Shestak A, et al.

    Genes 2022; (13(4)) doi:10.3390/genes13040559.

    PMID: 35456365
  34. 34

    CLINICAL CASES OF LIFE-THREATENING ARRHYTHMIAS: LONG AND SHORT QT SYNDROMES.

    Grytsay ON, Skybchyk YV, Shorikova DV, Shorikov EI

    Wiadomosci lekarskie (Warsaw, Poland : 1960) 2022; (75(7)):1805-1812 doi:10.36740/WLek202207113.

    PMID: 35962703
  35. 35

    Supraventricular tachyarrhythmia and sinus node dysfunction as a first manifestation of short QT syndrome in a pediatric patient. Case Report.

    Ploneda-Valencia RG, Ortiz-Solis WA, Ruiz-Gonzalez G, et al.

    Journal of electrocardiology 2022; (74()):146-153 doi:10.1016/j.jelectrocard.2022.08.010.

    PMID: 36240673
  36. 36

    Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review.

    Medeiros P, Santos M, Arantes C, et al.

    Heart & lung : the journal of critical care 2023; (60()):1-7 doi:10.1016/j.hrtlng.2023.02.012.

    PMID: 36863123
  37. 37

    Manual vs. automatic assessment of the QT-interval and corrected QT.

    Neumann B, Vink AS, Hermans BJM, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2023; (25(9)) doi:10.1093/europace/euad213.

    PMID: 37470430
  38. 38

    Are disease-specific patient-reported outcomes measures (PROMs) used in cardiogenetics? A systematic review.

    van Pottelberghe S, Kupper N, Scheirlynck E, et al.

    European journal of human genetics : EJHG 2024; (32(6)):607-618 doi:10.1038/s41431-023-01510-w.

    PMID: 38097768
  39. 39

    The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.

    Moreno-Manuel AI, Macías Á, Cruz FM, et al.

    Cardiovascular research 2024; (120(5)):490-505 doi:10.1093/cvr/cvae019.

    PMID: 38261726
  40. 40

    QTc Interval: A frequently unrecognized electrocardiographic interval.

    Ibrahim AOKZ, Prabhakar AP, Lopez-Candales A

    The American journal of the medical sciences 2024; (368(5)):532-537 doi:10.1016/j.amjms.2024.04.020.

    PMID: 38701971
  41. 41

    Congenital short QT syndrome: A review focused on electrocardiographic features.

    Pérez-Riera AR, Barbosa-Barros R, da Silva Rocha M, et al.

    Journal of electrocardiology 2024; (85()):87-94 doi:10.1016/j.jelectrocard.2024.04.009.

    PMID: 38714466
  42. 42

    Interpreting the actionable clinical role of rare variants associated with short QT syndrome.

    Martínez-Barrios E, Greco A, Cruzalegui J, et al.

    Human genetics 2024; (143(12)):1499-1508 doi:10.1007/s00439-024-02713-x.

    PMID: 39503779
  43. 43

    Alleviating the Effects of Short QT Syndrome Type 3 by Allele-Specific Suppression of the KCNJ2 Mutant Allele.

    Wilders R

    International journal of molecular sciences 2024; (25(24)) doi:10.3390/ijms252413351.

    PMID: 39769116
  44. 44

    The Uncommon Phenomenon of Short QT Syndrome: A Scoping Review of the Literature.

    Boulmpou A, Giannopoulos A, Papadopoulos C, et al.

    Journal of personalized medicine 2025; (15(3)) doi:10.3390/jpm15030105.

    PMID: 40137421
  45. 45

    Psychological Interventions for Reducing Distress in Patients with Cardiac Arrhythmias.

    Särnholm J, Gaffey AE, Turchio MR, et al.

    Current cardiology reports 2025; (27(1)):102.

    PMID: 40560300
  46. 46

    Management of channelopathies in children.

    Krause U

    Herzschrittmachertherapie & Elektrophysiologie 2025; (36(3)):186-191 doi:10.1007/s00399-025-01098-2.

    PMID: 40762707
  47. 47

    A comparison of the four most commonly used formulae to adjust the QT-interval for heart rate in 22,000 healthy subjects.

    Hoek LJ, Voors AA, Maass AH, et al.

    Journal of electrocardiology 2025; (92()):154091 doi:10.1016/j.jelectrocard.2025.154091.

    PMID: 40829441
  48. 48

    Cardiac Channelopathies in the Pediatric Patient: Short QT Syndrome.

    Tan RB, Shah MJ

    Cardiac electrophysiology clinics 2025; (17(4)):645-650 doi:10.1016/j.ccep.2025.07.012.

    PMID: 41206177
  49. 49

    "What impact does having a diagnosis of an inherited cardiac condition have on children and young people's physical activity and quality of life?" A scoping review.

    Kendall S, Murugaperumal VMK, Greco A, et al.

    European journal of pediatrics 2026; (185(1)):55 doi:10.1007/s00431-025-06658-9.

    PMID: 41493623
  50. 50

    Finding a new rhythm: child health-related quality of life, parent psychological distress, and unmet needs among families of children with cardiac channelopathies.

    McElduff ML, Turner C, Costa DSJ, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2026; (35(1)):25 doi:10.1007/s11136-025-04141-4.

    PMID: 41493667
  51. 51

    Familial Short QT Syndrome: Phenotypic Variability and Challenges in Risk Stratification.

    Bouzón P, Alen A, Salgado M, et al.

    Journal of clinical medicine 2026; (15(9)) doi:10.3390/jcm15093461.

    PMID: 42123196
  52. 52

    Successful extravascular implantable cardioverter-defibrillator implantation in a patient with short QT syndrome: A case report.

    Kodera N, Nishii N, Ueoka A, et al.

    Journal of cardiology cases 2026; (34(4)):139-143 doi:10.1016/j.jccase.2026.06.002.

    PMID: 42889605